Cancer Research
World-class cancer research, and product development is carried out in a number of hospitals, research institutions and companies in the region:
The Christie Hospital NHS Trust in Manchester. This is the largest cancer treatment centre of its kind in Europe, and second in the world only to MD Anderson in Houston. The Christie is a significant centre for clinical trials with access to a large patient population via the cancer network.
The Paterson Institute for Cancer Research in Manchester. The institute receives £8million annually from charitable sources, notably Cancer Research UK, and is part of the Christie Trust. The Institute is also developing a Translational Research Centre that will include the latest facilities for gene therapy, molecular diagnostics, and pharmacokinetics and pharmacodynamic studies.
Wolfson Molecular Imaging Centre (WMIC) adjacent to the Christie Hospital and the Paterson Institute for Cancer Research. This centre, the first of its kind in the world, provides imaging for cancer research using Positron Emission Tomography (PET) and also houses a cyclotron source with a GMP manufacturing laboratory for testing short-lived radiolabelled drugs.
The
University of Liverpool Cancer Research Centre and
institute of Cancer Studies. The new ULCRC is undertaking a wide
range of research into cancer, as well as training scientists and
health workers. The University is already internationally
renowned for its research work in the areas of gastric, colon,
pancreatic, breast and lung cancer. Partners include: Royal
Liverpool University Hospital, Clatterbridge Centre for Oncology
and the NW Cancer Research fund.
Linda McCartney Centre in Liverpool. The centre
provides treatment for breast cancer, liver/colorectal cancer, eye
cancer, chemotherapy and bone marrow transplantation.
Cancer Tissue
Bank Research Centre, University of Liverpool. Established in
1991 with support from
AstraZeneca, Alderley Park in Cheshire. Research and development is carried out in the areas of cancer, anaesthetics and heart disease. AstraZeneca are world leaders in drug development for the treatment of prostate cancer (e.g. Casodex, the world's leading anti-androgen therapy) and breast cancer (e.g. Nolvadex, the world's most commonly-prescribed breast cancer treatment).
Epistem in Manchester. Epistem provides a pre-clinical contract research service focused upon epithelial tissues and their stem cells with specific expertise in cancers and cancer therapy side effects.
Photo Therapeutics in Cheshire. The company develops photodynamic therapies for the treatment of non-melanoma skin cancer and precursor legions.
TheRyte in Liverpool. TheRyte develop protein markers for cancer diagnostics and drug development.
